Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


2nd Enhancing Drug Bioavailability & Solubility

21 Jan 2013 - 23 Jan 2013 - Boston, MA, USA



Bookmark and Share


Based on the successes of our inaugural Enhancing Drug Bioavailability and Solubility Conference in 2012, ExL Pharma brings together the industry’s leading formulation experts together to share and discuss emerging drug bioavailability and solubility enhancement strategies. Learn from the industry's most accomplished drug formulation and preformulation experts. Join 125+ executives from 80+ leading organizations to discuss and hear unique take-home examples, case studies and multiple formulation and preformulation strategies to assist in improving drug solubility and bioavailability, maximizing exposure, and reducing time-to-market on future drug products.


 What Will You Learn?


Rationale formulation design for poorly soluble compounds

Pharmaceutical formulation development strategies: Considerations for successful product development

Improving oral bioavailability for poorly water-soluble drug candidates 

Experimental methods for investigating and maintaining supersaturation to enhance drug bioavailability

Solubilities of crystalline drugs in polymers

Solubilization approaches for parenteral routes of administration

Product diversification and enhancement through pre-formulation technologies

Patent opportunities for solubility solutions 

Enhancing API bioavailability via nanotechnology for drug delivery  

Application of nanotechnology for the enhancement of skin permeability for poorly soluble compounds

Improving oral modified release dosage forms 



Further information
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Improved Stability, Shelf Life of Protein Drugs
Study improves protein drug stability and extend their shelf life by tested a novel route for non-covalent protein modification.
Biological Link between the Gut Microbiome and Parkinson’s Disease
The findings suggest that targeting the gut microbiome may provide a new approach for diagnosing and treating Parkinson’s disease.
Protein-Based “Cancer Signature” Uncovered
Researchers investigated the expression of ribosomal proteins in human tissues and discovered a cancer type specific signature which could be used to predict the progression of the disease.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
How the Brain Recognizes Faces
Machine-learning system spontaneously reproduces aspects of human neurology.
Boosting Effectiveness of Asthma Therapy
A team of scientists from UCSF has developed a new treatment to dampen bronchospasm.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!